XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Pfizer to sell about $3.25 bln stake in Sensodyne-maker Haleon, bookrunner says



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon</title></head><body>

Placing at a 3.3% discount to Haleon's last close

Haleon to buy back 230 mln stg worth of shares from Pfizer

Pfizer to remain top Haleon shareholder -LSEG data

Updates dateline to Oct. 1, recasts with final pricing, shares, other details throughout

By Shanima A

Oct 1 (Reuters) -Pfizer PFE.N sold a stake in British consumer healthcare group Haleon HLN.L worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.6%.

Shares in Haleon, which was created by the merger of GSK GSK.L and Pfizer's consumer healthcare businesses in 2019 and spun off from the British drugmaker in 2022, fell 1.2% to 388 pence in morning trade on Tuesday.

The Pfizer shares were placed at 380 pence each, a discount of 3.3% to Haleon's last closing price.

Pfizer, which remains the largest shareholder in Haleon following the sale, had said last year that it planned to cut its ownership in a "slow and methodical" manner within months.

The U.S. drug giant had intended to sell about 540 million shares in Haleon, a bookrunner on the deal said late on Monday, adding this was raised 100 million shares due to strong demand.

Haleon separately confirmed it will buy about 60.5 million of its shares from Pfizer at the same price for a total of 230 million pounds ($307.4 million).

BofA Securities and Goldman Sachs Internationalacted as joint global coordinators and joint bookrunners on the sale.

Pfizer sold about $3.5 billion worth of Haleon shares in March, with GSK disposing of its entire stake in May.

In August, Haleon forecast high single-digit growth in organic operating profit in 2024 amid strong demand for its oral care products and vitamins.

($1 = 0.7463 pounds)



Reporting by Shanima A and Prerna Bedi in Bengaluru; Editing by Shailesh Kuber, Sriraj Kalluvila, Anna Driver and Alexander Smith

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.